专题：Estrogen and related hormone effects

This cluster of papers explores the mechanisms of estrogen receptor signaling, with a focus on its role in breast cancer, interactions with glucocorticoids, and the effects of various drugs such as tamoxifen and aromatase inhibitors. It delves into the molecular pathways, gene regulation, and coactivator/coregulator dynamics involved in estrogen signaling.
最新文献
Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study

article Full Text OpenAlex

19O AIMET: A EURACAN multicenter pilot study of aromatase inhibitors plus metformin on recurrent granulosa cell tumors

article Full Text OpenAlex

Molecular Mechanisms and Therapeutic Strategies to Overcome Resistance to Endocrine Therapy and CDK4/6 Inhibitors in Advanced ER+/HER2- Breast Cancer

preprint Full Text OpenAlex

Analysis of the Main Directions in the Development of Mono and Combination Pharmacotherapy Acting on Hormonal Signaling Pathways of Breast Cancer According to the FDA Databases and Clinicaltrials.gov

article Full Text OpenAlex

Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer

article Full Text OpenAlex

Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer

review Full Text OpenAlex

β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis

article Full Text OpenAlex

Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis

article Full Text OpenAlex

Update of the impact of menopausal hormone therapy on breast cancer risk

article Full Text OpenAlex

Sex hormones, the anticancer immune response, and therapeutic opportunities

review Full Text OpenAlex

近5年高被引文献
The 2022 hormone therapy position statement of The North American Menopause Society

article Full Text OpenAlex 441 FWCI94.104

Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

article Full Text OpenAlex 324 FWCI49.535

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer

review Full Text OpenAlex 235 FWCI9.155

Antibody–drug conjugates: Recent advances in linker chemistry

review Full Text OpenAlex 213 FWCI6.756

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer

review Full Text OpenAlex 205 FWCI6.393

Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans

review Full Text OpenAlex 202 FWCI9.011

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

review Full Text OpenAlex 194 FWCI11.302

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

article Full Text OpenAlex 188 FWCI29.517

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years

review Full Text OpenAlex 180 FWCI10.364

Menopause transition: Physiology and symptoms

review Full Text OpenAlex 167 FWCI9.382